Convidecia

Convidecia (pronounced: /kɒnvɪˈdiːʃə/) is a term used in the medical field, specifically in relation to the COVID-19 pandemic.

Etymology

The term "Convidecia" is derived from the name of the virus that causes COVID-19, SARS-CoV-2, and the Latin word "videre", which means "to see". This name was chosen to represent the hope that this vaccine will help us "see" the end of the pandemic.

Definition

Convidecia is the name of a vaccine developed by CanSino Biologics for the prevention of COVID-19. It is a viral vector vaccine that uses a human adenovirus to deliver a modified spike protein to cells in order to stimulate an immune response.

Related Terms

• Vaccine
• COVID-19
• SARS-CoV-2
• Adenovirus
• Immune response
• CanSino Biologics

See Also

• Viral vector vaccine
• Pandemic
• Immunization

External links

• Medical encyclopedia article on Convidecia
• Wikipedia's article - Convidecia

This WikiMD article is a stub. You can help make it a full article.

---

Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski